BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leiguarda C, Villarreal A, Potilinski C, Pelissier T, Coronel MF, Bayo J, Ramos AJ, Montaner A, Villar MJ, Constandil L, Brumovsky PR. Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization. J Neuroimmune Pharmacol 2021. [PMID: 33502706 DOI: 10.1007/s11481-021-09983-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Guo P, Ma Z, Lu P, Kebebe D, Liu Z. Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review. J Nanobiotechnology 2021;19:255. [PMID: 34425832 DOI: 10.1186/s12951-021-01002-3] [Reference Citation Analysis]
2 Zhang G, Tian C, Liang T, Chi H, Wu A, Li J, Yao X, Wang Q, Zhu C, Lin N. The analgesic properties of Yu-Xue-Bi tablets in the inflammatory pain mice: By the inhibition of CCL3-mediated macrophage transmigration into the spinal cord. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115051] [Reference Citation Analysis]